All interventions

Complementary OXYT

Oxytocin

Oxytocin is a neuropeptide hormone that plays a crucial role in social bonding, trust, and emotional regulation.

It is naturally produced in the hypothalamus and released into the bloodstream and brain, where it influences various aspects of social behavior. In clinical settings, oxytocin is mainly administered intranasally to target the central nervous system directly.

Due to its significant role in social cognition and behavior, oxytocin has been studied as a potential therapeutic agent for Autism Spectrum Disorder (ASD) with the aim of improving social functioning. Nasal administration allows oxytocin to cross the blood-brain barrier more efficiently, facilitating its action on brain regions involved in social cognition.

Interventions based on intranasal oxytocin administration are grounded in its involvement in enhancing social cognition, including theory of mind and empathy (Hammock et al., 2015). The proposed mechanisms of action include:

  • Fear Reduction: Oxytocin may reduce fear and anxiety, making social interactions less intimidating and more manageable for individuals with ASD.
  • Increased Social Motivation: By enhancing the reward system associated with social interactions, oxytocin may increase the desire to engage in social activities.
  • Improved Detection of Social Cues: Oxytocin might enhance the ability to recognize and interpret social signals, such as facial expressions and body language, thereby improving social communication.

Commonly, oxytocin is administered in dosages ranging from 18 to 40 international units (IU) per day, divided into multiple doses. It is essential for these interventions to be supervised by healthcare professionals to ensure safety and monitor for any potential side effects, such as nasal irritation or headaches.

Number of meta-analyses

  • Preschool (0-5): no meta-analysis
  • School-age (6-12): 29 meta-analyses
  • Adolescents (13-17): 11 meta-analyses
  • Adults (18+): 23 meta-analyses

One meta-analysis per outcome and age group, shown in the Intervention explorer.

See its evidence